Text Size
1 study found for:    22047971 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Active, not recruiting A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ocrelizumab;   Drug: placebo;   Drug: methylprednisolone;   Drug: interferon beta-1a
To Top

† Indicates status has not been verified in more than two years